Onconova Therapeutics Inc.

06/28/2024 | Press release | Distributed by Public on 06/28/2024 15:01

Certificate of Incorporation/Bylaws Form 8 K

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 26, 2024, the Board adopted an amendment to the Company's Amended and Restated Bylaws (the "Bylaws Amendment"), solely to reduce the quorum requirement for all meetings of stockholders of the Company from a majority of the issued and outstanding shares of the Company's common stock, par value $0.01 per share ("Common Stock") to one-third of the issued and outstanding shares of Common Stock.

The foregoing description of the Bylaws Amendment is a summary and is qualified in its entirety by reference to the full text of the Bylaws Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.